pharma · Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma · metastatic or unresectable, recurrent HNSCC
Createrna Science and
Wuhan Createrna Science and Technology Co., Ltd
Createrna Science and clinical programs — 13 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- shanghai, CN, London
- Employees
- 26
- Programs
- 51
- Drugs
- 87
- Patents
- 0
Createrna Science and projects
13 ClinicalTrials.gov programs sponsored by Createrna Science and.
Createrna Science and has 13 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AC-203-EBS-007
Wuhan Createrna Science and Technology Co., Ltd
Generalized Epidermolysis Bullosa Simplex (EBS)
1 trial -
ALKS 4230-007
Wuhan Createrna Science and Technology Co., Ltd
Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
1 trial -
AT148006
Wuhan Createrna Science and Technology Co., Ltd
Patients with HER2-overexpressing advanced or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma that has progressed on or after a prior HER2-directed agent and fluoropyrimidine- or platinum-containing chemotherapy (2nd-line or 3rd-line)
1 trial -
BASICstudy
Wuhan Createrna Science and Technology Co., Ltd
Chronic cluster headache
1 trial -
HOVON 127 BL
Wuhan Createrna Science and Technology Co., Ltd
Burkitt lymphoma
1 trial -
IMFINZI 50 mg/mL concentrate for solution for infusion.
Wuhan Createrna Science and Technology Co., Ltd
Small-cell lung cancer, extensive stage
1 trial -
LOXO-BTK-20019
Wuhan Createrna Science and Technology Co., Ltd
Mantle cell lymphoma
1 trial -
LOXO-BTK-20020
Wuhan Createrna Science and Technology Co., Ltd
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
1 trial -
LOXO-BTK-20022
Wuhan Createrna Science and Technology Co., Ltd
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-322)
1 trial -
LOXO-BTK-20023
Wuhan Createrna Science and Technology Co., Ltd
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
1 trial -
LOXO-BTK-20030
Wuhan Createrna Science and Technology Co., Ltd
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
1 trial -
LY06006/MRCT-301
Wuhan Createrna Science and Technology Co., Ltd
Postmenopausal osteoporosis
1 trial -
TRIO041
Wuhan Createrna Science and Technology Co., Ltd
Intermediate-stage hepatocellular carcinoma with beyond up-to-7 criteria.
1 trial
Frequently asked questions
How many clinical projects does Createrna Science and have?
13 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.